Latest Happenings in Business World
15
Dec-2021
North America followed by Europe dominated the global skin analysis systems market in 2020.
As per our research report, the global skin analysis systems market size is estimated to be growing at a CAGR of 9.04% from 2021 to 2026.
The pandemic has significantly affected the skin analysis systems market due to manufacturing, supply chain issues, and product launch delays. In early 2020, the COVID-19 disease started to spread worldwide. Millions of people worldwide have been infected with COVID-19 infection, and major countries across the globe have restricted non-emergency treatments, putting the skin analysis systems market under huge losses. As a result, dermatology and cosmetic procedures were kept on hold until the phase of active–infection was passed on. However, in the latter half of 2020, the market grew substantially with the increased influx of patients with up-lifting restrictions. Therefore, the pandemic will not have long-term effects on the projected growth of the market over the forecast period.
The growing prevalence of skin diseases, concerns for youthfulness, and healthy skin are key factors driving the skin analysis systems market. According to the US Department of Health and Human Services, more than 3.58 million people are diagnosed with skin cancer each year in the United States. According to the WHO, approximately 3.18% of the adult American population suffered from psoriasis in 2010. Increased skin exposure to UV rays and chemicals, pollution, stressful lifestyle, and genetic predisposition to skin disorders are other factors expected to help the market grow. Constantly evolving health technologies and innovations are the key factors in the early detection of skin disorders. Therefore, it contributes significantly to the growth of the skin analysis systems market.
With urbanization resulting in increased awareness of people's appearance and aesthetic appeal, there is an enormous demand for skin diagnosis and treatment procedures. Furthermore, emphasis is placed on educating the public about melanoma and non-melanoma skin cancers. Early detection of this highly- aggressive improves prognosis rate with improved, powerful, and futuristic tools in the skin analysis systems market. According to the CDC, recorded data shows that nearly 77,700 new cases of melanoma are reported each year in the U.S; this includes 45,855 men and 31,850 women. Overall, the incidence rate for melanoma was indicated to be 21.85 per 100,000. According to Ferlay et al., over 26,200 males and 33,500 females are diagnosed with melanoma each year. Around 8,350 males and 7,650 females face death due to cancer-related complications, making this the 8th most commonly diagnosed cancer in females.
However, strict regulations regarding product approval, poor pricing strategies, and growing consumer demand for inexpensive products restrict the skin analysis systems market. Additionally, the lack of adequate training in the handling of the instruments restricts the growth of the global skin analysis systems market.
KEY MARKET INSIGHTS:
MARKET SEGMENTATION:
By Product:
By End-User:
By Region:
WRITTEN BY: Market Data Forecast
Market Data Forecast